Literature DB >> 29459060

Bickerstaff's brainstem encephalitis with overlapping Guillain-Barré syndrome: Usefulness of sequential nerve conduction studies.

Choong Yi Fong1, Hnin Wint Wint Aung2, Arie Khairani3, Chin Seng Gan4, Nortina Shahrizaila5, Khean Jin Goh5.   

Abstract

Bickerstaff's brainstem encephalitis (BBE) is a rare immune-mediated disorder characterized by ophthalmoplegia, ataxia and disturbance of consciousness, which may overlap with Guillain-Barré syndrome (GBS) if there is additional limb weakness. We report a 7-month-old boy presented with ophthalmoplegia followed by a rapidly ascending paralysis of all four limbs and disturbance of consciousness. The initial impression was BBE with overlapping GBS. This was supported by sequential nerve conduction study (NCS) findings compatible with an acute inflammatory demyelinating polyneuropathy (AIDP). He received intravenous pulse methylprednisolone, intravenous immunoglobulin and plasmapharesis with complete clinical recovery after 6 weeks of illness and improved NCS findings from week 16. This is the first case of paediatric BBE with overlapping GBS with an AIDP subtype of GBS. It expands the clinical spectrum of this condition in children. Our case highlights the importance of sequential NCS in paediatric BBE with overlapping GBS for accurate electrophysiological diagnosis and prognosis particularly if the first NCS findings are not informative.
Copyright © 2018 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute inflammatory demyelinating polyneuropathy; Bickerstaff’s brainstem encephalitis; Gullain-Barré syndrome; Nerve conduction study

Mesh:

Year:  2018        PMID: 29459060     DOI: 10.1016/j.braindev.2018.02.001

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  1 in total

1.  Effect of Electromyographic Biofeedback Therapy on Muscle Strength Recovery in Children with Guillain-Barré Syndrome.

Authors:  Qianqian Liu; Jianhua Xue; Pingping Zhao; Yue Ling; Suzhe Liu; Yakun Du; Ning Han; Mingxia Liu; Wei Di
Journal:  J Healthc Eng       Date:  2021-12-23       Impact factor: 2.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.